Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
USANA Health Sciences Inc(USNA)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for USNA
09/28/2026: USNA (1-star) is currently NOT-A-BUY. Pass it for now.
USANA Health Sciences is a consumer-focused company that sells nutritional supplements and skincare products through a direct-selling model. Its main strength lies in its debt-free balance sheet, commitment to in-house manufacturing, and a strong, science-backed product reputation. The company's primary growth story revolves around digital transformation to better support its associate network and expansion into new markets. However, investors face significant risks from heavy reliance on direct-selling, high geographic concentration, and intense competition from mass-market retailers. USANA may best suit investors comfortable with the risks of network marketing who monitor its ability to modernize digital platforms and navigate evolving international regulations.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Growth is currently constrained by the maturity of the direct-selling model in key regions. |
| Momentum investor | Weak fit | The stock has struggled to maintain consistent upward momentum amid regional revenue pressures. |
| Value investor | Strong fit while signal remains positive | The company's clean balance sheet and valuation often appeal to those seeking fundamental value. |
| Dividend investor | Weak fit | USANA does not pay a regular dividend, making it unsuitable for income-focused portfolios. |
| Low-risk investor | Mixed fit | The business faces regulatory and geopolitical risks that introduce volatility not ideal for low-risk strategies. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | Changes in international regulatory environments often cause significant share price swings. |
| Valuation risk | Medium | While typically reasonably priced, market sentiment toward direct-selling can depress valuations. |
| Competition risk (direct-selling) | High | High competition from e-commerce and other direct-selling firms impacts customer retention. |
| Business quality | Medium | Strong manufacturing quality is offset by the inherent model risk of direct-selling. |
| Dividend income | Low / none | Investors receive no yield from the stock. |
| Execution risk | Medium / high | Success depends heavily on the company's ability to motivate and retain independent associates. |
Price Behavior
Downtrend
The stock has experienced a sustained decline in price over recent periods.
Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -57.06% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/28/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 273.82M USD | Price to earnings Ratio - | 1Y Target Price 25 |
Price to earnings Ratio - | 1Y Target Price 25 | ||
Volume (30-day avg) 207.3K shares | Beta 0.68 | 52 Weeks Range 12.57 - 27.95 | Updated Date 09/29/2026 |
52 Weeks Range 12.57 - 27.95 | Updated Date 09/29/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.21 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Nutritionals | CellSentials and specialty supplements sold to distributors. | This is the primary revenue engine for the company. |
| Asia-Pacific Geography | Sales generated in China and surrounding regions. | This region is the most critical driver of total company revenue and growth. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE 7.93 | Enterprise Value 110.66M | Price to Sales(TTM) 0.3 |
Enterprise Value 110.66M | Price to Sales(TTM) 0.3 | ||
Enterprise Value to Revenue 0.12 | Enterprise Value to EBITDA 2.65 | Shares Outstanding 18.48M | Shares Floating 9.93M |
Shares Outstanding 18.48M | Shares Floating 9.93M | ||
Percent Insiders 40.88 | Percent Institutions 63.4 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About USANA Health Sciences Inc
Exchange NYSE | Headquarters Salt Lake City, UT, United States | ||
IPO Launch date 1996-07-25 | CEO & Executive Chairman Mr. Kevin G. Guest | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 1570 | Website https://www.usana.com |
Full time employees 1570 | Website https://www.usana.com | ||
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.